Pyxis Oncology Ratios (2020-2025) | PYXS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)													97.06%					100.00%		78.37%
EBT Margin (Quarter)													-72.66%					-640.82%		-154.04%
EBIT Margin (Quarter)													-34.71%					-700.35%		-165.75%
EBITDA Margin (Quarter)													-34.71%					-700.35%		-165.75%
Operating Margin (Quarter)													-34.71%					-700.35%		-165.75%
Net Margin (Quarter)													-72.66%					-650.85%		-166.60%
FCF Margin (Quarter)													-129.73%					-612.16%		-94.46%
Efficiency
Assets Average (Quarter)				209.75M	266.36M	247.63M	233.23M	217.64M	197.09M	179.02M	180.96M	180.21M	196.97M	214.30M	201.85M	176.25M	146.52M	129.54M	114.41M	98.56M
Asset Utilization Ratio (Quarter)																0.09		0.02	0.02	0.14
Leverage & Solvency
Interest Coverage Ratio (Quarter)			-0.33	-1.00	-71.34	-1.91	-2.17	59.61	-3.97	-17.41	-224.37	10.46	-0.73	-4.97	-4.51	-44.77	-28.64	-24.69	-3.81	7.59
Times Interest Earned (Quarter)			-0.33	-1.00	-71.34	-1.91	-2.17	59.61	-3.97	-17.41	-224.37	10.46	-0.73	-4.97	-4.51	-44.77	-28.64	-24.69	-3.81	7.59
Valuation
Enterprise Value (Quarter)	-140.66M	-142.47M	-133.48M	-276.21M	-248.56M	-224.83M	-200.01M	-180.76M	-54.53M	-27.37M	-132.97M	-119.30M	-29.44M	-26.55M	-144.82M	-126.93M	-14.23M	-12.21M	-76.26M	-66.86M
Return Ratios
Return on Sales (Quarter)													-0.01%			-0.05%		-0.07%	-0.35%	-0.02%
Return on Capital Employed (Quarter)				-36.49%	-26.45%	-36.59%	-47.60%	-66.39%	-60.94%	-62.10%	-67.09%	-53.22%	-36.56%	-34.83%	-37.00%	-56.42%	-80.83%	-95.19%	-111.75%	-109.03%
Return on Assets (Quarter)				-0.01%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%